The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888
Self-citationPsychological Assessment Resources
Abidin, R. R. (1995) · Medical Entomology and Zoology · Cited by 3,147
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Neurotrophins and Neuronal Plasticity
Thoenen, H. (1995) · Science · doi:10.1126/science.270.5236.593 · Cited by 1,927
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
Psychopharmacology: The Fourth Generation of Progress
Brophy, J. J. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530220079046 · Cited by 1,582
BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
Hyman, C., Hofer, M., Barde, Y.-A., Juhasz, M., Yancopoulos, G. D., Squinto, S. P., & Lindsay, R. M. (1991) · Nature · doi:10.1038/350230a0 · Cited by 1,494
Molecular cloning and expression of brain-derived neurotrophic factor
Leibrock, J., Lottspeich, F., Hohn, A., Hofer, M., Hengerer, B., Masiakowski, P., Thoenen, H., & Barde, Y.-A. (1989) · Nature · doi:10.1038/341149a0 · Cited by 1,457
Cited by
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
Miranda, M., Morici, J. F., Zanoni, M. B., & Bekinschtein, P. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00363 · Cited by 1,416
Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders
Autry, A. E., & Monteggia, L. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005108 · Cited by 1,390
“…studies have shown that BDNF expression is increased in the frontal cortices of patients with SZ compared with controls (Takahashi et al., 2000), whereas others report that BDNF and TrkB are decreased in the cortices of patients with schizophrenia (Weickert et al., 2003; Hashimoto et al., 2005b).”
BackgroundResultLasting epigenetic influence of early-life adversity on the BDNF gene
Roth, T. L., Lubin, F. D., Funk, A. J., & Sweatt, J. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.028 · Cited by 1,273
Pezawas, L., Verchinski, B. A., Mattay, V. S., Callicott, J. H., Kolachana, B. S., Straub, R. E., Egan, M. F., Meyer-Lindenberg, A., & Weinberger, D. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2680-04.2004 · Cited by 890
Self-citationEpigenetic Regulation of bdnf Gene Transcription in the Consolidation of Fear Memory
Lubin, F. D., Roth, T. L., & Sweatt, J. D. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1786-08.2008 · Cited by 793
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
Lima Giacobbo, B., Doorduin, J., Klein, H. C., Dierckx, R. A. J. O., Bromberg, E., & de Vries, E. F. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1283-6 · Cited by 750
(Patho)physiological Significance of the Serum- and Glucocorticoid-Inducible Kinase Isoforms
Lang, F., Böhmer, C., Palmada, M., Seebohm, G., Strutz-Seebohm, N., & Vallon, V. (2006) · Physiological Reviews · doi:10.1152/physrev.00050.2005 · Cited by 689
“such as schizophrenia (364), depression (319), and Alzheimer’s disease (220).”
BackgroundPsychosis and autism as diametrical disorders of the social brain
Crespi, B., & Badcock, C. (2008) · Behavioral and Brain Sciences · doi:10.1017/s0140525x08004214 · Cited by 604
Role of Neurotrophic Factors in the Etiology and Treatment of Mood Disorders
Duman, R. S. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:1:011 · Cited by 537
Kipnis, J., Cohen, H., Cardon, M., Ziv, Y., & Schwartz, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402268101 · Cited by 510
Hashimoto, T., Arion, D., Unger, T., Maldonado-Avilés, J. G., Morris, H. M., Volk, D. W., Mirnics, K., & Lewis, D. A. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002011 · Cited by 490
Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis
Green, M. J., Matheson, S. L., Shepherd, A., Weickert, C. S., & Carr, V. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.88 · Cited by 453
Self-citationDNA methylation of BDNF as a biomarker of early-life adversity
Kundakovic, M., Gudsnuk, K., Herbstman, J. B., Tang, D., Perera, F. P., & Champagne, F. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408355111 · Cited by 426
GABAergic Interneurons Shape the Functional Maturation of the Cortex
Le Magueresse, C., & Monyer, H. (2013) · Neuron · doi:10.1016/j.neuron.2013.01.011 · Cited by 425
Dysregulation of the fibroblast growth factor system in major depression
Evans, S. J., Choudary, P. V., Neal, C. R., Li, J. Z., Vawter, M. P., Tomita, H., Lopez, J. F., Thompson, R. C., Meng, F., Stead, J. D., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406788101 · Cited by 424
Ayalew, M., Le-Niculescu, H., Levey, D. F., Jain, N., Changala, B., Patel, S. D., Winiger, E., Breier, A., Shekhar, A., Amdur, R., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.37 · Cited by 397
Hashimoto, T., Bergen, S. E., Nguyen, Q. L., Xu, B., Monteggia, L. M., Pierri, J. N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4035-04.2005 · Cited by 384
Fung, S. J., Webster, M. J., Sivagnanasundaram, S., Duncan, C., Elashoff, M., & Weickert, C. S. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09060784 · Cited by 366
Self-citationNeurobiology of Dopamine in Schizophrenia
Guillin, O., Abi‐Dargham, A., & Laruelle, M. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78001-1 · Cited by 365
“2000) have shown increased and two decreased (Hashimoto et al. 2005; Weickert et al. 2003) BDNF levels in the brain of patients with schizophrenia.”
BackgroundNeuroplasticity of Neocortical Circuits in Schizophrenia
Lewis, D. A., & González-Burgos, G. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301563 · Cited by 365
Akbarian, S., & Huang, H.-S. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.04.001 · Cited by 363
Ray, M. T., Weickert, C. S., Wyatt, E., & Webster, M. J. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100048 · Cited by 354
Self-citationWeickert, C. S., Straub, R. E., McClintock, B. W., Matsumoto, M., Hashimoto, R., Hyde, T. M., Herman, M. M., Weinberger, D. R., & Kleinman, J. E. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.6.544 · Cited by 352
Self-citationClinical relevance of the neurotrophins and their receptors
Allen, S. J., & Dawbarn, D. (2006) · Clinical Science · doi:10.1042/cs20050161 · Cited by 320
Roceri, M., Cirulli, F., Pessina, C., Peretto, P., Racagni, G., & Riva, M. A. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.011 · Cited by 317
Neuroinflammation in schizophrenia especially focused on the role of microglia
Monji, A., Kato, T. A., Mizoguchi, Y., Horikawa, H., Seki, Y., Kasai, M., Yamauchi, Y., Yamada, S., & Kanba, S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.002 · Cited by 314
Kim, A. H., Reimers, M., Maher, B., Williamson, V., McMichael, O., McClay, J. L., van den Oord, E. J. C. G., Riley, B. P., Kendler, K. S., & Vladimirov, V. I. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.002 · Cited by 298
“BDNF mRNA levels have been shown to be significantly reduced in the DLPFC of schizophrenics (Weickert et al., 2003).”
BackgroundApoptotic mechanisms and the synaptic pathology of schizophrenia
Glantz, L. A., Gilmore, J. H., Lieberman, J. A., & Jarskog, L. F. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.014 · Cited by 292
Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia
Hashimoto, R., Straub, R. E., Weickert, C. S., Hyde, T. M., Kleinman, J. E., & Weinberger, D. R. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001434 · Cited by 283
Self-citationEpigenetic Regulation of the BDNF Gene: Implications for Psychiatric Disorders
Boulle, F., van den Hove, D. L. A., Jakob, S. B., Rutten, B. P., Hamon, M., van Os, J., Lesch, K.-P., Lanfumey, L., Steinbusch, H. W., & Kenis, G. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.107 · Cited by 282
Serum neurotrophins—A study on the time course and influencing factors in a large old age sample
Ziegenhorn, A. A., Schulte-Herbrüggen, O., Danker-Hopfe, H., Malbranc, M., Hartung, H.-D., Anders, D., Lang, U. E., Steinhagen-Thiessen, E., Schaub, R. T., & Hellweg, R. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.011 · Cited by 278
Mellios, N., Huang, H.-S., Grigorenko, A., Rogaev, E., & Akbarian, S. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn201 · Cited by 274
“S2), is of particular interest given the fact that this neuronal population displays alterations in dendritic spine density (45) and soma size (46) in schizophrenia, a disease where deficits in BDNF levels have been reported in some postmortem cohorts (15,24).”
BackgroundPillai, A., Kale, A., Joshi, S., Naphade, N., Raju, M. S. V. K., Nasrallah, H., & Mahadik, S. P. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709991015 · Cited by 274
Mellios, N., Huang, H.-S., Baker, S. P., Galdzicka, M., Ginns, E., & Akbarian, S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.019 · Cited by 266
Prenatal stressors in rodents: Effects on behavior
Weinstock, M. (2017) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.08.004 · Cited by 264
Neurotrophin signalling: novel insights into mechanisms and pathophysiology
Mitre, M., Mariga, A., & Chao, M. V. (2017) · Clinical Science · doi:10.1042/cs20160044 · Cited by 263
Cattaneo, A., Cattane, N., Begni, V, Pariante, C. M., & Riva, M. A. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.214 · Cited by 244
Vostrikov, V. M., Uranova, N. A., & Orlovskaya, D. D. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.04.014 · Cited by 233
“Post-mortem studies demonstrate a reduction in BDNF, neuregulin 1 (NRG 1) and neurotrophin receptors production in the PFC of SCH and MDD patients (Angelucci et al., 2005; Hashimoto et al., 2004; Weickert et al., 2003).”
BackgroundFillman, S. G., Sinclair, D., Fung, S. J., Webster, M. J., & Shannon Weickert, C. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.8 · Cited by 226
GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders
Sibille, E., Morris, H. M., Kota, R. S., & Lewis, D. A. (2011) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001616 · Cited by 217
Balu, D. T., Li, Y., Puhl, M. D., Benneyworth, M. A., Basu, A. C., Takagi, S., Bolshakov, V. Y., & Coyle, J. T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304308110 · Cited by 217
“The expression of BDNF mRNA and protein is reduced in the dorsolateral prefrontal cortex (PFC) of subjects with schizophrenia (8); another study demonstrated a positive correlation between reduced BDNF mRNA levels and reduced spine density in the same subjects with schizophrenia (58).”
BackgroundYee, B. K., Keist, R., von Boehmer, L., Studer, R., Benke, D., Hagenbuch, N., Dong, Y., Malenka, R. C., Fritschy, J.-M., Bluethmann, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508752102 · Cited by 201
DNA methylation of the BDNF gene and its relevance to psychiatric disorders
Ikegame, T., Bundo, M., Murata, Y., Kasai, K., Kato, T., & Iwamoto, K. (2013) · Journal of Human Genetics · doi:10.1038/jhg.2013.65 · Cited by 179
Elman, I., Borsook, D., & Lukas, S. E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301051 · Cited by 169
Ray, M. T., Shannon Weickert, C., & Webster, M. J. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.26 · Cited by 161
Notaras, M., Lodhi, A., Dündar, F., Collier, P., Sayles, N. M., Tilgner, H., Greening, D., & Colak, D. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01316-6 · Cited by 150
Pırıldar, Ş., Gönül, A. S., Taneli, F., & Akdeniz, F. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.008 · Cited by 142
Jay, T. M., Rocher, C., Hotte, M., Naudon, L., Gurden, H., & Spedding, M. (2004) · Neurotoxicity Research · doi:10.1007/bf03033225 · Cited by 141
“…plasticity like DARPP-32 (32-kD dopamine and cyclic adenosine monophosphate-regulated phosphoprotein) are found to be associated with the corticolimbic system and particularly the prefrontal cortex of schizophrenic patients (Takahashi et al., 2000; Albert et al., 2002; Weickert et al., 2003).”
BackgroundTejeda, G., & Díaz-Guerra, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020268 · Cited by 126
“Simultaneously, alterations in BDNF protein [160,161] and total mRNA have been observed in postmortem prefrontal cortex from patients [161,162].”
Backgroundde Bartolomeis, A., Barone, A., Vellucci, L., Mazza, B., Austin, M. C., Iasevoli, F., & Ciccarelli, M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02976-3 · Cited by 113
Brain-derived neurotrophic factor and schizophrenia
Di Carlo, P., Punzi, G., & Ursini, G. (2019) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000237 · Cited by 110
“The age-related decline of BDNF in the blood is consistent with the dynamic observed in the brain (Weickert et al., 2003; Mellios et al., 2009).”
ResultThe Physiology of BDNF and Its Relationship with ADHD
Liu, D.-Y., Shen, X.-M., Yuan, F.-F., Guo, O.-Y., Zhong, Y., Chen, J.-G., Zhu, L.-Q., & Wu, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8956-6 · Cited by 106
Yamamori, H., Hashimoto, R., Ishima, T., Kishi, F., Yasuda, Y., Ohi, K., Fujimoto, M., Umeda-Yano, S., Ito, A., Hashimoto, K., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.059 · Cited by 101
Hill, R. A., Wu, Y. W. C., Kwek, P., & Buuse, M. V. D. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02277.x · Cited by 96
Gamma oscillation deficits and the onset and early progression of schizophrenia
Woo, T.-U. W., Spencer, K., & McCarley, R. W. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673221003747609 · Cited by 96
Cell biology of BDNF and its relevance to schizophrenia
Lu, B., & Martinowich, K. (2008) · Novartis Foundation Symposia · doi:10.1002/9780470751251.ch10 · Cited by 92
O'Sullivan, E., Barrett, E., Grenham, S., Fitzgerald, P., Stanton, C., Ross, R., Quigley, E., Cryan, J., & Dinan, T. (2011) · Beneficial Microbes · doi:10.3920/bm2011.0015 · Cited by 92
Orefice, L. L., Waterhouse, E. G., Partridge, J. G., Lalchandani, R. R., Vicini, S., & Xu, B. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0012-13.2013 · Cited by 87
Sinclair, D., Fullerton, J. M., Webster, M. J., & Shannon Weickert, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031720 · Cited by 71
“At the molecular level, numerous mRNA transcripts and proteins are altered in both schizophrenia and bipolar disorder, including brain-derived neurotrophic factor (BDNF), glutamic acid decarboxylase-67 (GAD-67) and growth-associated protein-43 (GAP-43) [32–38].”
BackgroundSinclair, D., Webster, M. J., Wong, J., & Weickert, C. S. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.28 · Cited by 66
Luo, C., Xu, H., & Li, X.-M. (2004) · Brain Research · doi:10.1016/j.brainres.2004.06.089 · Cited by 66
Anticipated brain molecular aging in major depression
Douillard-Guilloux, G., Guilloux, J.-P., Lewis, D. A., & Sibille, E. (2013) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.040 · Cited by 62
BDNF rs6265 methylation and genotype interact on risk for schizophrenia
Ursini, G., Cavalleri, T., Fazio, L., Angrisano, T., Iacovelli, L., Porcelli, A., Maddalena, G., Punzi, G., Mancini, M., Gelao, B., et al. (2016) · Epigenetics · doi:10.1080/15592294.2015.1117736 · Cited by 62
Li, J., Ye, F., Xiao, W., Tang, X., Sha, W., Zhang, X., & Wang, J. (2016) · European Psychiatry · doi:10.1016/j.eurpsy.2016.03.005 · Cited by 53
Cholinergic Circuits and Signaling in the Pathophysiology of Schizophrenia
Berman, J. A., Talmage, D. A., & Role, L. W. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78007-2 · Cited by 47
“[PubMed: 16675398] Ward NL, Hagg T. BDNF is needed for postnatal maturation of basal forebrain and neostriatum cholinergic neurons in vivo.”
BackgroundInfluentialde Bartolomeis, A., Buonaguro, E. F., Latte, G., Rossi, R., Marmo, F., Iasevoli, F., & Tomasetti, C. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00240 · Cited by 44
“In post-mortem studies, a decrease in BDNF levels in frontal cortices (Weickert et al., 2003) and an increase in hippocampus have been reported in schizophrenia patients (Iritani et al., 2003).”
BackgroundWong, J., Duncan, C. E., Beveridge, N. J., Webster, M. J., Cairns, M. J., & Shannon Weickert, C. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr177 · Cited by 43
Jones, N. C., Hudson, M., Foreman, J., Rind, G., Hill, R., Manning, E. E., & van den Buuse, M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13722 · Cited by 20
Metadata
- Authors
- Weickert, C. S., Hyde, T. M., Lipska, B. K., Herman, M. M., Weinberger, D. R., & Kleinman, J. E.
- Venue
- Molecular Psychiatry
- Published
- 2003-06-01
- Volume
- 8
- Issue
- 6
- Pages
- 592-610
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2032804593
- Cited by
- 532
- References
- 133
- FWCI
- 15.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.